Disruption or reduction of claudin-5 may be involved in the pathophysiology of various diseases, including schizophrenia, depression, and Alzheimer’s disease [33,34,35]. The gene discussed is CLDN5; the disease is early-onset autosomal dominant Alzheimer disease.